Top Markets
#1 Velas Velas +367.73%
#2 Gravity Gravity +49.04%
#3 Galxe Galxe +34.81%
#4 Derive Derive +31.02%
#5 Infinity Ground Infinity Ground +29.01%
#6 Audiera Audiera +25.57%
#7 Wiki Cat Wiki Cat +25.37%
#8 Wrapped QUIL Wrapped QUIL +22.19%
#9 Aria.AI Aria.AI +21.09%
#10 Fetch.ai Fetch.ai +20.92%
Coin of the day
Velas Velas
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
MultiCell Technologies, Inc. MultiCell Technologies, Inc.

MultiCell Technologies, Inc.

MCET
Classificação em ações #20716
MultiCell Technologies, Inc., a biopharmaceutical company, develops novel... MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc. in April 2004. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island.
Preço da ação
$0.00001
Valor de mercado
$50.01K
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar MultiCell Technologies, Inc. (MCET)

Categoria

Healthcare
Capitalização de Mercado
Receita
mais
Lucros
Histórico de Preços
Índice P/E
Índice P/S
Índice P/B
Margem Operacional
EPS
Divisões de Ações
Dividendos
Rendimento de Dividendos
Ações em Circulação
Rácio P/S de MultiCell Technologies, Inc. (MCET)
Rácio P/S em March 2026 TTM: 1.01K
De acordo com os relatórios financeiros mais recentes e o preço das ações da MultiCell Technologies, Inc., o rácio P/S atual (TTM) é 1.01K. No final de 2013, o rácio P/S era 27.21.
Histórico do rácio P/S da MultiCell Technologies, Inc. de 2013 a 2026
Rácio P/S no final de cada ano
Ano Rácio P/S Alterar
2026 (TTM) 1.01K 3,255.43%
2014 30.22 11.07%
2013 27.21 0.00%
Rácio P/S de empresas semelhantes ou concorrentes
Empresa Rácio P/S Diferença do rácio P/S País
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
3.55 -99.65%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.90 -99.02%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
5.40 -99.47%
US
UCB SA UCB SA
UCB SA
UCB.BR
6.14 -99.39%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.04 -99.70%
AU